Forbes February 3, 2023
Joshua Cohen

Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.

By paying a monthly flat fee of $5 an Amazon Prime members can obtain as many generic drugs as they need, among an initial set of 50 medications indicated for conditions, such as high blood pressure, anxiety, and male pattern baldness. Amazon’s new initiative will operate within its existing pharmacy infrastructure and distribution channels.

Paying a low, flat cash rate for generics isn’t unprecedented. Walmart, among others, has such a program.

And, for two years Mark Cuban’s Cost Plus Drug Company (MCCPDC) has been making waves in the cash business for generic...

Today's Sponsors


Today's Sponsor


Topics: Pharma, Pharma / Biotech
Vertex Pays CRISPR Therapeutics $100M to Bring Gene-Editing to Type 1 Diabetes
The Role of the Pharmacy Technician Expanded During the COVID-19 Pandemic
US spent $4.3 trillion on healthcare in 2021: Here's how
Amazon underestimated complexity of healthcare: Report
Court Ruling Leaves 340B Providers Waiting for Clarity About the Use of Contract Pharmacies

Share This Article